Original BioMedicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	133.85	151.45	228.68	13.98	8.46
Short-Term Investments	9.99	89.74	99.8	34.93	74.85
Cash & Short-Term Investments	143.84	241.19	328.48	48.91	83.31
Cash Growth	-40.36%	-26.57%	571.60%	-41.29%	928.77%
Other Receivables	13.99	13.51	11.55	9.99	9.59
Receivables	13.99	13.51	11.55	9.99	9.59
Other Current Assets	6.2	1.61	1.37	0.89	1.55
Total Current Assets	164.03	256.31	341.4	59.79	94.46
Property, Plant & Equipment	18.75	21.9	28.08	36.19	41.03
Other Long-Term Assets	1.16	1.16	1.16	2.05	1.88
Total Assets	183.94	279.37	370.63	98.04	137.37
Accrued Expenses	10.56	8.56	7.48	4.29	3.93
Current Portion of Leases	4.17	4.52	4.26	3.62	3.14
Other Current Liabilities	2.12	1.35	18.12	2.46	1.44
Total Current Liabilities	16.84	14.43	29.86	10.36	8.52
Long-Term Leases	7.03	7.47	11.98	16.27	17.52
Other Long-Term Liabilities	2.23	2.23	2.23	2.23	2.23
Total Liabilities	26.1	24.12	44.07	28.86	28.26
Common Stock	665.89	659.92	655.5	470.5	470.5
Additional Paid-In Capital	1.06	384.17	384.9	252.85	252.51
Retained Earnings	-509.12	-788.83	-713.84	-654.18	-613.9
Shareholders' Equity	157.84	255.25	326.57	69.17	109.11
Total Liabilities & Equity	183.94	279.37	370.63	98.04	137.37
Total Debt	11.19	11.98	16.24	19.89	20.66
Net Cash (Debt)	132.65	229.21	312.24	29.02	62.65
Net Cash Growth	-42.13%	-26.59%	976.08%	-53.69%	-
Net Cash Per Share	2.00	3.47	6.33	0.62	1.51
Filing Date Shares Outstanding	66.59	65.99	65.55	47.05	47.05
Total Common Shares Outstanding	66.59	65.99	65.55	47.05	47.05
Working Capital	147.18	241.88	311.54	49.43	85.94
Book Value Per Share	2.37	3.87	4.98	1.47	2.32
Tangible Book Value	157.84	255.25	326.57	69.17	109.11
Tangible Book Value Per Share	2.37	3.87	4.98	1.47	2.32
Machinery	4.67	44.92	47.15	46.96	46.84
Leasehold Improvements	36.85	36.85	36.85	36.73	36.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.